EMJ·3 min read·hard
Serum REG3α for Ulcerative Colitis Monitoring
J
Josh Lister
✦AI Summary
A study suggests that the serum REG3α biomarker could be an effective tool for monitoring disease activity in patients with ulcerative colitis. Researchers found that combining this biomarker with C-reactive protein improves diagnostic accuracy.
SERUM REG3α biomarker testing was associated with clinical and endoscopic disease activity in patients with ulcerative colitis, supporting its potential as a blood-based adjunct for disease monitoring. The findings also suggest improved performance when interpreted alongside C reactive protein (CRP), although further validation is needed.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in